🟢 Cue Biopharma is trading 5.45% up today — no clear catalyst identified

Cue Biopharma is trading 5.45% higher at $28.93, with no clearly reported company-specific catalyst identified for September 8, 2026.

• Broader markets are weaker, so market direction does not explain the gain.
• The latest identified company news predates September 8, including an August 3 CFO appointment and CUE-221 regulatory update.
• Reason remains unclear pending possible delayed disclosure.